Last reviewed · How we verify
NCT04633798
Evaluation of the Efficacy of Intense Pulse Light Combined With Lipiflow in the Treatment of Meibomian Gland Dysfunction
NA trial testing IPL/Lipiflow in Meibomian Gland Dysfunction in 100 participants. Status unknown.
21 December 2020
Quick facts
| Lead sponsor | Aier School of Ophthalmology, Central South University |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 December 2020 |
| Primary completion | 21 December 2020 |
| Estimated completion | 21 December 2020 |
Drugs / interventions tested
- IPL/Lipiflow
- IPL/MGX
Conditions studied
- Meibomian Gland Dysfunction — all drugs for Meibomian Gland Dysfunction →
Sponsor
Aier School of Ophthalmology, Central South University
Who can join
Adults 18 to 80, any sex, with Meibomian Gland Dysfunction. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
To compare the effect of IPL combined with lipiflow and IPL combined with meibomian gland massage in treating meibomian gland dysfunction of different degrees ,focusing on effective rate, lasting time and changes of meibomian gland function and morphology.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
LipiFlow for the treatment of dry eye disease.
Pucker AD, Yim TW, Rueff E, Ngo W, et al · · 2024 · cited 11× · PMID 38314898 · DOI 10.1002/14651858.cd015448.pub2
Verify or expand the search:
- PubMed search for NCT04633798
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Meibomian Gland Dysfunction
Currently open trials in the same condition.
- NCT06220474 — Therapeutic Efficacy and Safety of Non-Invasive RF Treatment in Refractory MGD · NA · recruiting
- NCT06371300 — Photobiomodulation With REd vs BluE Light (REBEL) · NA · recruiting
- NCT06054217 — Effect of an Exploratory Vehicle on Meibomian Gland Dysfunction in Patients With Demodex · Phase 2 · active not recruiting
- NCT03652337 — Meibomian Gland Dysfunction Management · NA · active not recruiting
Other Aier School of Ophthalmology, Central South University trials
Trials by the same sponsor.
- NCT05718076 — Trifocal Intraocular Lens in High Myopic Patients With Different Meta-PM Grading · unknown
- NCT04927117 — Evaluation of Visual Acuity in Myopic Cataract Patients Using Trifocal Intraocular Lens · unknown
- NCT04569422 — Influence of Obuvacaine Hydrochloride Eye Drops on the Comfort of Meibomian Gland Massage Patients · unknown
- NCT04400097 — The Influence of Suture Method in Conjunctival Autograft Transplantation on Postoperative Ocular Discomfort for Primary · NA · unknown
- NCT03998384 — A New Treatment of Retinitis Pigmentosa · NA · unknown
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04633798 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aier School of Ophthalmology, Central South University
- Last refreshed: 18 November 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04633798.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing